Yuan Y, Liu X, Cai Y, Li W, et al. Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review. PLoS One 2023;18:e0279775.
PMID: 36602979